According to Grifols's latest financial reports and stock price the company's current Operating Margin is 11.25%. At the end of 2022 the company had an Operating Margin of 5.96%.
Year | Operating Margin | Change |
---|---|---|
2022 | 5.96% | -16.14% |
2021 | 7.10% | -56.82% |
2020 | 16.45% | 2.67% |
2019 | 16.03% | -0.94% |
2018 | 16.18% | 0.41% |
2017 | 16.11% | -8.45% |
2016 | 17.60% | 0.32% |
2015 | 17.54% | -0.18% |
2014 | 17.57% | -3.16% |
2013 | 18.15% | 22.6% |
2012 | 14.80% | 232.13% |
2011 | 4.46% | -72.02% |
2010 | 15.93% | -28.71% |
2009 | 22.34% | 5.59% |
2008 | 21.16% | 20.39% |
2007 | 17.57% | 79.52% |
2006 | 9.79% | 25.72% |
2005 | 7.79% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | 22.88% | 103.38% | ๐บ๐ธ USA |
Amgen AMGN | 34.59% | 207.47% | ๐บ๐ธ USA |
Baxter BAX | -19.01% | -268.98% | ๐บ๐ธ USA |
Kimberly-Clark KMB | 9.31% | -17.24% | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.